{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:57:06Z","timestamp":1791863826946,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K76AG083287"],"award-info":[{"award-number":["K76AG083287"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpainsymman.2026.04.604","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:13:11Z","timestamp":1776294791000},"page":"e80-e87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-8612","authenticated-orcid":false,"given":"Paul","family":"Noufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-9527","authenticated-orcid":false,"given":"Joshua B.","family":"Borris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6219-7619","authenticated-orcid":false,"given":"Danielle","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-1421","authenticated-orcid":false,"given":"Cara L.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-9374","authenticated-orcid":false,"given":"Nneka N.","family":"Ufere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-9499","authenticated-orcid":false,"given":"Jason A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8168-2255","authenticated-orcid":false,"given":"Daniel","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"Mclntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: the ketamine story \u2013 past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0004","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0006","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.14l09527","article-title":"Single-dose ketamine followed by daily d-cycloserine in treatment-resistant bipolar depression","volume":"76","author":"Kantrowitz","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0007","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.4088\/JCP.17f11681","article-title":"Ketamine for depression, 3: does chirality matter?","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0008","doi-asserted-by":"crossref","first-page":"e1414","DOI":"10.1097\/MJT.0000000000000257","article-title":"Ketamine-A narrative review of its uses in medicine","volume":"23","author":"Radvansky","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0009","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1475-6773.12479","article-title":"Identifying older adults with serious illness: a critical step toward improving the value of health care","volume":"52","author":"Kelley","year":"2017","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0014","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","article-title":"Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review","volume":"8","author":"Walsh","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0016","article-title":"Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder","volume":"2021","author":"Dean","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0017","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0018","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jad.2024.04.039","article-title":"Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: a systematic review and meta-analysis","volume":"356","author":"Calder","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0019","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S2215-0366(17)30480-7","article-title":"Can we confidently use ketamine as a clinical treatment for depression?","volume":"5","author":"Loo","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41398-024-03033-4","article-title":"Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study","volume":"14","author":"Pan","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0023","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0024","series-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor","year":"2019"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ijnp\/pyaa033","article-title":"Pharmacological augmentation in unipolar depression: a guide to the guidelines","volume":"23","author":"Taylor","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0026","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.7326\/M22-1603","article-title":"The Management of major depressive disorder: synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice guideline","volume":"175","author":"McQuaid","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.64719\/pb.4413","article-title":"Developing an IV Ketamine clinic for treatment-resistant depression: a primer","volume":"51","author":"Parikh","year":"2021","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0028","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jad.2024.03.137","article-title":"Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for major depression: a systematic review and meta-analysis","volume":"356","author":"Seshadri","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.2018.196","article-title":"Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"214","author":"Domany","year":"2019","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0032","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881118760660","article-title":"Repeated intranasal ketamine for treatment-resistant depression \u2013 the way to go? Results from a pilot randomised controlled trial","volume":"32","author":"G\u00e1lvez","year":"2018","journal-title":"J Psychopharmacol (Oxf)"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0033","first-page":"1157","article-title":"Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression","volume":"238","author":"Siegel","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0034","series-title":"\u0405\u0440ravat\u03bf (\u0435\u0455k\u0435tamin\u0435) [prescribing information]","year":"2023"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0035","series-title":"\u0405\u0440r\u0430vat\u043e (\u0435sk\u0435t\u0430mine) [product monograph]","year":"2022"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0036","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40263-023-01026-3","article-title":"Efficacy and safety of esketamine nasal spray in patients with treatment-resistant depression who completed a second induction period: analysis of the ongoing SUSTAIN-3 study","volume":"37","author":"Castro","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression\u2014TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0038","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0039","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03005598","article-title":"Continuous subcutaneous injection of ketamine for cancer pain","volume":"37","author":"Oshima","year":"1990","journal-title":"Can J Anaesth J Can Anesth"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0040","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1089\/jpm.2018.0627","article-title":"The efficacy of ketamine in the palliative care setting: a comprehensive review of the literature","volume":"22","author":"Goldman","year":"2019","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0041","first-page":"182","article-title":"Efficacy and safety of ketamine for the treatment of depressive symptoms in palliative care: a systematic review","volume":"45","author":"Barbosa","year":"2023","journal-title":"Rev Bras Psiquiatr Sao Paulo Braz 1999"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0042","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11372.1","article-title":"Ketamine for pain","volume":"6","author":"Jonkman","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0043","article-title":"Ketamine as an adjuvant to opioids for cancer pain","volume":"6","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2023.100428","article-title":"The efficacy and safety of ketamine for depression in patients with cancer: a systematic review","volume":"24","author":"Azari","year":"2024","journal-title":"Int J Clin Health Psychol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3934\/publichealth.2023043","article-title":"Use of ketamine for depression and suicidality in cancer and terminal patients: review of current data","volume":"10","author":"Oyetunji","year":"2023","journal-title":"AIMS Public Health"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0046","first-page":"1560","article-title":"The efficacy of ketamine for acute and chronic pain in patients with cancer: a systematic review of randomized controlled trials","volume":"12","author":"Azari","year":"2024","journal-title":"Healthc Basel Switz"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0047","first-page":"S552","article-title":"Effect of intraoperative single administration of sub-anesthesia ketamine on breast cancer patients with depression","author":"Xu","year":"2017","journal-title":"Biomed Res (Tokyo)"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.818822","article-title":"Effects of a single sub-anesthetic dose of ketamine on postoperative emotional responses and inflammatory factors in colorectal cancer patients","volume":"13","author":"Ren","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0049","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1213\/ANE.0000000000005752","article-title":"Ketamine alleviates depressive symptoms in patients undergoing intracranial tumor resection: a randomized controlled trial","volume":"133","author":"Zhou","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/08941939.2019.1710626","article-title":"Effect of pretreatment of S-ketamine on postoperative depression for breast cancer patients","volume":"34","author":"Liu","year":"2021","journal-title":"J Invest Surg"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0051","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/j.clbc.2024.06.003","article-title":"S-ketamine infusion on chronic postoperative pain following breast cancer surgery: a randomized double-blind placebo-controlled trial","volume":"24","author":"Guo","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0052","article-title":"Use of various doses of S-ketamine in treatment of depression and pain in cervical carcinoma patients with mild\/moderate depression after laparoscopic total hysterectomy","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0053","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.18632\/oncotarget.13743","article-title":"Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial","volume":"8","author":"Fan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0054","article-title":"Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-phase II single-arm open-label feasibility study","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/cancers15020400","article-title":"A phase II, open-label clinical trial of intranasal ketamine for depression in patients with cancer receiving palliative care (INKeD-PC Study)","volume":"15","author":"Rosenblat","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12904-019-0499-1","article-title":"A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study","volume":"19","author":"Falk","year":"2020","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0057","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/jpm.2012.0319","article-title":"Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice","volume":"16","author":"Irwin","year":"2013","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0058","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.psym.2014.05.005","article-title":"Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases","volume":"56","author":"Iglewicz","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0059","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1017\/S1478951524000798","article-title":"Ketamine subcutaneous continuous infusion for depressive symptoms at home: a case report beyond pain use","volume":"22","author":"Sim\u00f5es","year":"2024","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/S1478951523000317","article-title":"Effect of a single dose of intravenous ketamine on the wish to hasten death in palliative care: a case report in advanced cancer","volume":"21","author":"Decazes","year":"2023","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0061","first-page":"131","article-title":"Adjunctive intranasal esketamine for comorbid treatment-resistant depression with suicidal ideation in patients receiving palliative care at a comprehensive cancer center: a case series","volume":"28","author":"Tomy","year":"2025","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0062","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/pon.5586","article-title":"Is ketamine a litmus test for capacity in assisted dying with depression?","volume":"30","author":"Rosenblat","year":"2021","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0063","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamaoncol.2018.0131","article-title":"Oral ketamine vs placebo in patients with cancer-related neuropathic pain","volume":"4","author":"Fallon","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0064","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jpm.2011.0353","article-title":"Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care","volume":"15","author":"Salas","year":"2012","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14740338.2022.2069749","article-title":"Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability","volume":"21","author":"Kritzer","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0066","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/14740338.2022.2047928","article-title":"Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"21","author":"Bahji","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0067","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2023.10.120","article-title":"A systematic review of the incidence of medical serious adverse events in sub-anesthetic ketamine treatment of psychiatric disorders","volume":"345","author":"Hovda","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0068","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.jpainsymman.2023.11.004","article-title":"Efficacy and safety of ketamine to treat cancer pain in adult patients: a systematic review","volume":"67","author":"Jiao","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0069","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13730-020-00557-8","article-title":"The role of short-term, low dose intravenous ketamine infusion in calciphylaxis","volume":"10","author":"Ghanavatian","year":"2021","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpainsymman.2007.10.002","article-title":"Use of ketamine for ischemic pain in end-stage renal failure","volume":"35","author":"Capel","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-024-03176-4","article-title":"Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury","volume":"14","author":"Huang","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0072","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40263-020-00699-4","article-title":"Cardiac safety of esketamine nasal spray in treatment-resistant depression: results from the clinical development program","volume":"34","author":"Doherty","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0073","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jad.2018.02.025","article-title":"Blood pressure safety of subanesthetic ketamine for depression: a report on 684 infusions","volume":"236","author":"Riva-Posse","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0074","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0269881120936909","article-title":"Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression","volume":"35","author":"Zhou","year":"2021","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2026.04.604_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapsychiatry.2023.4945","article-title":"The rapidly shifting ketamine landscape in the US","volume":"81","author":"Wilkinson","year":"2024","journal-title":"JAMA Psychiatry"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426007554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426007554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T02:02:39Z","timestamp":1783216959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392426007554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0885392426007554"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.04.604","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.04.604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}